Thermo Fisher Scientific Inc
TMO · NYSE
- $594.00
- $221.73B
- Open
- —
- —
- $0.00 - $0.00
- $435.27 - $643.99
- —
- —
- 1.86M
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells instruments, laboratory equipment, consumables, reagents, software and services used in research, diagnostics and biopharmaceutical production. Its reporting structure comprises Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services, with revenue generated from product sales, recurring consumables and technical or contract services. Customers include pharmaceutical and biotechnology companies, academic and government research institutions, clinical laboratories and healthcare providers. The company reported $44.6 billion of fiscal 2025 revenue and $6.7 billion of net income, compared with $42.9 billion and $6.3 billion, respectively, in fiscal 2024.
Notable Price Movement
- Aug 3-7$594.003.43%
Thermo Fisher shares fell $11.66, or 2.02%, from $576.41 to $564.75 over the supplied week. The stock was essentially flat through July 30, edging up to $576.77, then weakened to $574.30 on July 31 and slipped again on August 3 before dropping 1.62% on August 4. The supplied evidence does not identify a dated company-specific trading catalyst for the decline. It does highlight a favorable backdrop—Thermo Fisher raised its 2026 outlook after strong second-quarter results, citing demand, acquisitions and margin gains—but does not establish that this news drove the week’s price action. No broader-market or sector performance context was provided.
